Name: ACAD Insider Trading Activity
Creator: Tracefour
License: https://www.usa.gov/government-works
Keywords: ACAD, insider trading, SEC Form 4, insider transactions

Question 1

How many SEC Form 4 insider filings does ACAD have?

Accepted Answer

ACADIA PHARMACEUTICALS INC (ACAD) has 13 SEC Form 4 filings (18 transaction rows) in the rolling 365-day window, disclosed by 2 distinct insiders. Most recent filing: Jun 29, 2026.

Question 2

When was the most recent SEC Form 4 filing for ACAD?

Accepted Answer

The most recent Form 4 filing for ACAD on Tracefour is dated Jun 29, 2026.

Question 3

Who is the most active insider at ACAD?

Accepted Answer

The most active SEC Form 4 filer at ACAD in the rolling window is PRINCIPAL ACCOUNTING OFFICER Kihara James, with 4 filings.

Question 4

What is the net insider flow at ACAD over the last 6 months?

Accepted Answer

Over the trailing 180 days, insiders at ACAD have net sold $601K based on SEC Form 4 disclosures.

Question 5

What is the total insider buy and sell value at ACAD in the current window?

Accepted Answer

Inside the rolling window, insiders at ACAD bought $0 and sold $601K based on SEC Form 4 filings.

						Source
Kihara James	PRINCIPAL ACCOUNTING OFFICER	Sale	11,421	$298K	Jun 29	SEC ↗
Kihara James	PRINCIPAL ACCOUNTING OFFICER	Sale	5,401	$114K	May 27	SEC ↗
Kihara James	PRINCIPAL ACCOUNTING OFFICER	Sale	1,332	$29K	May 5	SEC ↗
Schneyer Mark C.	EVP, CHIEF FINANCIAL OFFICER	Sale	3,506	$76K	May 5	SEC ↗
Kihara JamesFirst filing	PRINCIPAL ACCOUNTING OFFICER	Sale	1,030	$23K	Apr 7	SEC ↗
Schneyer Mark C.First filing	EVP, CHIEF FINANCIAL OFFICER	Sale	2,709	$60K	Apr 7	SEC ↗

ACAD

Related companies